Logo Logo

Publications by Pena, C.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Dreyling, M.; Morschhauser, F.; Bouabdallah, K.; Bron, D.; Cunningham, D.; Assouline, S. E.; Verhoef, G.; Linton, K.; Thieblemont, C.; Vitolo, U.; Hiemeyer, F.; Giurescu, M.; Garcia-Vargas, J.; Gorbatchevsky, I.; Liu, L.; Koechert, K.; Pena, C.; Neves, M.; Childs, B. H.; Zinzani, P. L. (2017): Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma. In: Annals of Oncology, Vol. 28, No. 9: pp. 2169-2178

Liu, L.; Köchert, K.; Seidel, H.; Garcia-Vargas, J.; Childs, B. H.; Follows, G.; Bouabdallah, K.; Dreyling, M.; Pena, C. (2017): Tumor gene expression signatures of BCR/PI3K dependence in association with copanlisib monotherapy activity in heavily pretreated patients with indolent NHL and follicular lymphoma. In: Annals of Oncology, Vol. 28

Liu, L.; Koechert, K.; Cheng, J.; Garcia-Vargas, J.; Childs, B. H.; Dreyling, M.; Pena, C. (2016): Tumor gene expression profiles associated with single-agent copanlisib activity in heavily pretreated patients with indolent and aggressive non-hodgkin lymphoma (NHL). In: Haematologica, Vol. 101: p. 571

This list was generated on Thu Sep 19 07:44:53 2019 CEST.